BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 87558)

  • 21. [Pharma-clinics. Drug of the month. Polyvalent antipneumococcal vaccine (Pneumune)].
    Scheen AJ
    Rev Med Liege; 1996 Mar; 51(3):257-8. PubMed ID: 8668891
    [No Abstract]   [Full Text] [Related]  

  • 22. Prevention of pneumococcal infection by immunization with capsular polysaccharides of Streptococcus pneumoniae: current status of polyvalent vaccines.
    Austrian R
    J Infect Dis; 1977 Aug; 136 Suppl():S38-42. PubMed ID: 19543
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunodeficiency associated with recurrent infections and an isolated in vivo inability to respond to bacterial polysaccharides: follow-up immunization with pneumococcal polysaccharides.
    Gigliotti F
    Pediatr Infect Dis J; 1988 Aug; 7(8):604. PubMed ID: 3174304
    [No Abstract]   [Full Text] [Related]  

  • 24. A comparison of early and late vaccination with Haemophilus influenzae type b conjugate and pneumococcal polysaccharide vaccines after allogeneic BMT.
    Parkkali T; Käyhty H; Ruutu T; Volin L; Eskola J; Ruutu P
    Bone Marrow Transplant; 1996 Nov; 18(5):961-7. PubMed ID: 8932852
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pneumococcal conjugate vaccine primes for polysaccharide-inducible IgG2 antibody response in children with recurrent otitis media acuta.
    Breukels MA; Rijkers GT; Voorhorst-Ogink MM; Zegers BJ; Sanders LA
    J Infect Dis; 1999 May; 179(5):1152-6. PubMed ID: 10191217
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pneumococcal antibodies measured with a rapid enzyme-linked-immunosorbent assay (ELISA), using the whole vaccine as antigen. Suggestions for clinical application.
    Snijder JA; Löwenberg A; Klompmaker I; Weits J
    Neth J Med; 1988 Aug; 33(1-2):52-9. PubMed ID: 3247011
    [No Abstract]   [Full Text] [Related]  

  • 27. Capsular polysaccharides as human vaccines.
    Jennings HJ
    Adv Carbohydr Chem Biochem; 1983; 41():155-208. PubMed ID: 6195893
    [No Abstract]   [Full Text] [Related]  

  • 28. Pneumococcal vaccines in adults: assessing the evolving evidence.
    Grabenstein JD; Manoff SB
    Vaccine; 2011 Aug; 29(37):6149-54. PubMed ID: 21763386
    [No Abstract]   [Full Text] [Related]  

  • 29. Protection against infections with Streptococcus pneumoniae and Haemophilus influenzae type B in a population of splenectomized individuals with varying vaccination status.
    Konradsen HB; Rasmussen C; Ejstrud P; Hansen JB
    Adv Exp Med Biol; 1997; 418():833-5. PubMed ID: 9331782
    [No Abstract]   [Full Text] [Related]  

  • 30. [New vaccines].
    Ozişik A; Ustaçelebi S
    Mikrobiyol Bul; 1992 Jan; 26(1):82-9. PubMed ID: 1574025
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pneumococcal conjugate vaccines.
    Eskola J; Anttila M
    Pediatr Infect Dis J; 1999 Jun; 18(6):543-51. PubMed ID: 10391188
    [No Abstract]   [Full Text] [Related]  

  • 32. New challenges in the development of a conjugate pneumococcal vaccine.
    Baltimore RS
    JAMA; 1992 Dec; 268(23):3366-7. PubMed ID: 1453531
    [No Abstract]   [Full Text] [Related]  

  • 33. Haemophilus influenzae type B polysaccharide-protein conjugates: model for a new generation of capsular polysaccharide vaccines.
    Schneerson R; Robbins JB; Barrera O; Sutton A; Habig WB; Hardegree MC; Chaimovich J
    Prog Clin Biol Res; 1980; 47():77-94. PubMed ID: 6970933
    [No Abstract]   [Full Text] [Related]  

  • 34. Hemophilus type b polysaccharide vaccine. Committee on Infectious Diseases.
    Pediatrics; 1985 Aug; 76(2):322-4. PubMed ID: 3875076
    [No Abstract]   [Full Text] [Related]  

  • 35. New bacterial vaccines.
    Mäkelä PH
    Pediatr Infect Dis; 1982; 1(5):291-4. PubMed ID: 6818533
    [No Abstract]   [Full Text] [Related]  

  • 36. Clinical trial of the protective role of polyvalent pneumococcal vaccine in sickle cell anaemia patients in Zambia.
    Chintu C; Gupta K; Osborne C; Masona JM
    Med J Zambia; 1983 Jul; 17(3):73-6. PubMed ID: 6679155
    [No Abstract]   [Full Text] [Related]  

  • 37. [Immunological principles of polysaccharide-protein conjugate vaccination].
    Meyer M; Gahr M
    Monatsschr Kinderheilkd; 1993 Oct; 141(10):770-6; quiz 777, 812-3. PubMed ID: 7505396
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Pneumococcal vaccination].
    Léophonte P
    Rev Mal Respir; 1999 Nov; 16(5):763-6. PubMed ID: 10612144
    [No Abstract]   [Full Text] [Related]  

  • 39. Intact antibody response to pneumococcal capsular polysaccharides in uremia and diabetes.
    Friedman EA; Beyer MM; Hirsch SR; Schiffman G
    JAMA; 1980 Nov; 244(20):2310-1. PubMed ID: 7431555
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predominance of nontypeable Haemophilus influenzae in children with otitis media following introduction of a 3+0 pneumococcal conjugate vaccine schedule.
    Wiertsema SP; Kirkham LA; Corscadden KJ; Mowe EN; Bowman JM; Jacoby P; Francis R; Vijayasekaran S; Coates HL; Riley TV; Richmond P
    Vaccine; 2011 Jul; 29(32):5163-70. PubMed ID: 21621576
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.